Modifier Genes in Microcephaly: A Report on WDR62, CEP63, RAD50 and PCNT Variants Exacerbating Disease Caused by Biallelic Mutations of ASPM and CENPJ

View/ Open
Access
info:eu-repo/semantics/openAccessDate
2021Author
Makhdoom, Ehtisham Ul HaqWaseem, Syeda Seema
Iqbal, Maria
Abdullah, Uzma
Hussain, Ghulam
Asif, Maria
Budde, Birgit
Höhne, Wolfgang
Tinschert, Sigrid
Saadi, Saadia Maryam
Yousaf, Hammad
Ali, Zafar
Fatima, Ambrin
Kaygusuz, Emrah
Khan, Ayaz
Jameel, Muhammad
Khan, Sheraz
Tariq, Muhammad
Anjum, Iram
Altmüller, Janine
Thiele, Holger
Höning, Stefan
Metadata
Show full item recordCitation
Makhdoom, E. U. H., Waseem, S. S., Iqbal, M., Abdullah, U., Hussain, G., Asif, M., ... & Hussain, M. S. (2021). Modifier Genes in Microcephaly: A Report on WDR62, CEP63, RAD50 and PCNT Variants Exacerbating Disease Caused by Biallelic Mutations of ASPM and CENPJ. Genes, 12(5), 731.Abstract
Congenital microcephaly is the clinical presentation of significantly reduced head circumference at birth. It manifests as both non-syndromic—microcephaly primary hereditary (MCPH)—and syndromic forms and shows considerable inter- and intrafamilial variability. It has been hypothesized that additional genetic variants may be responsible for this variability, but data are sparse. We have conducted deep phenotyping and genotyping of five Pakistani multiplex families with either MCPH (n = 3) or Seckel syndrome (n = 2). In addition to homozygous causal variants in ASPM or CENPJ, we discovered additional heterozygous modifier variants in WDR62, CEP63, RAD50 and PCNT—genes already known to be associated with neurological disorders. MCPH patients carrying an additional heterozygous modifier variant showed more severe phenotypic features. Likewise, the phenotype of Seckel syndrome caused by a novel CENPJ variant was aggravated to microcephalic osteodysplastic primordial dwarfism type II (MOPDII) in conjunction with an additional PCNT variant. We show that the CENPJ missense variant impairs splicing and decreases protein expression. We also observed centrosome amplification errors in patient cells, which were twofold higher in MOPDII as compared to Seckel cells. Taken together, these observations advocate for consideration of additional variants in related genes for their role in modifying the expressivity of the phenotype and need to be considered in genetic counseling and risk assessment.
Volume
12Issue
5URI
https://www.mdpi.com/2073-4425/12/5/731http://dx.doi.org/10.3390/genes12050731
https://hdl.handle.net/11552/1988